Alzheimer's disease causes a progressive dementia that currently affects over 35 million
individuals worldwide and is expected to affect 115 million by 2050 (ref. 1). There are no cures …

Background Proteins pathogenic in Alzheimer's disease (AD) were extracted from neurally
derived blood exosomes and quantified to develop biomarkers for the staging of sporadic AD. …

Background Accurate diagnosis and early detection of complex diseases, such as Parkinson's
disease, has the potential to be of great benefit for researchers and clinical practice. We …

BACKGROUND: The authors conducted a randomized clinical trial examining the effects of
modafinil in reducing persistent fatigue in patients after treatment for cancer and performed …

Background: AD causes visuospatial disorientation that is associated with posterior cortical
atrophy and impaired visual motion processing. Objective: The authors characterized …

Alzheimer’s disease (AD) is characterized by non-linear, genetic-driven pathophysiological
dynamics with high heterogeneity in biological alterations and disease spatial-temporal …

We examined the frequency of Parkinson disease with mild cognitive impairment (PD‐MCI)
and its subtypes and the accuracy of 3 cognitive scales for detecting PD‐MCI using the new …

The increasing number of afflicted individuals with late‐onset Alzheimer's disease (AD)
poses significant emotional and financial burden on the world's population. Therapeutics …

Objectives. To determine whether concussed students experience greater academic dysfunction
than students who sustain other injuries. Methods. We conducted a prospective cohort …

Objective The overall aim of this study was to examine the relationship between subjective
memory complaints and objective cognitive performance in perimenopausal women. The …